Document is current
Any future updates will be listed below
-
Authors
Dhingra, Lovedeep S
Croon, Philip M
Batinica, Bruno
Aminorroaya, Arya
Pedroso, Aline F
Khera, Rohan
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01AG089981)
Doris Duke Charitable Foundation (2022060)
- License Information
-
More Information
Article History
Received: 26 November 2025
Accepted: 13 February 2026
First Online: 16 March 2026
Declarations
:
: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: Dr. Khera is an Associate Editor of JAMA. He receives support from the National Institutes of Health (under awards R01AG089981, R01HL167858, and K23HL153775) and the Doris Duke Charitable Foundation (under award 2022060). He also receives research support, through Yale, from Bristol-Myers Squibb, BridgeBio, and Novo Nordisk. In addition, Dr. Khera is a coinventor of U.S. Pending Patent Applications WO2023230345A1, US20220336048A1, 63/484,426, 63/508,315, 63/580,137, 63/606,203, 63/619,241, 63/562,335, and 63/346,610. Dr. Khera is also a co-founder of Ensight-AI and Evidence2Health, precision health platforms to improve evidence-based cardiovascular care. The other authors do not have competing interests to report.
